危重症患者的限时试验:文献综述
本综述旨在综合危重症患者限时试验的证据,明确已知内容与知识空白。共识别18项实证研究和15项伦理分析。观察性研究提示限时试验已在美国ICU实践中应用,但使用情况因单元和医生因素而异;部分ICU医生熟悉、认可并参与过限时试验,部分老年人似乎更倾向于限时试验策略而非无限期生命维持治疗或立即转向舒适照护。使用时限时试验常实施不完整,并受系统性障碍(如ICU人员持续轮转)挑战。一项前瞻性比较常规ICU照护与支持限时试验的干预研究得出有希望的初步结果。
要点
- 观察性研究提示限时试验已在美国ICU实践中应用,但使用情况因单元和医生因素而异。
- 部分ICU医生熟悉、认可并参与过限时试验;部分老年人似乎更倾向于限时试验而非无限期生命维持治疗或立即舒适照护。
- 使用时限时试验常实施不完整,并受系统性障碍挑战(如ICU人员持续轮转)。
- 预测建模研究支持临床共识:部分ICU患者预后不确定性随时间推移而降低。
- 一项前瞻性比较常规ICU照护与支持限时试验干预的研究得出有希望的初步结果。
适用人群与场景
- 危重症患者,涉及生命维持治疗获益与限度不确定时的决策场景。
研究设计与关键结果
- 综述识别18项实证研究和15项伦理分析。
- 观察性研究提示限时试验是美国ICU当前实践的一部分,但使用因单元和医生因素而异。
- 部分ICU医生熟悉、认可并参与过限时试验;部分老年人似乎更倾向于限时试验策略而非无限期生命维持治疗或立即转向舒适照护。
- 使用时限时试验常实施不完整,并受系统性障碍(如ICU人员持续轮转)挑战。
- 预测建模研究支持部分患者ICU预后不确定性随时间推移而降低。
- 一项前瞻性比较常规ICU照护与支持限时试验的干预研究得出有希望的初步结果。
- 伦理分析将限时试验描述为在长期关于不给予和撤除生命维持治疗讨论中的务实方法。
证据类型、等级与局限
- 证据类型:文献综述,汇总18项实证研究和15项伦理分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需大量努力来检验限时试验对以患者为中心结局的影响、改善其实施并最大化其潜在获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
TOPIC IMPORTANCE: Since the 1990s, time-limited trials have been described as an approach to navigate uncertain benefits and limits of life-sustaining therapies in patients with critical illness. In this review, we aim to synthesize the evidence on time-limited trials in critical care, establish what is known, and highlight important knowledge gaps.
REVIEW FINDINGS: We identified 18 empirical studies and 15 ethical analyses about time-limited trials in patients with critical illness. Observational studies suggest time-limited trials are part of current practice in ICUs in the United States, but their use varies according to unit and physician factors. Some ICU physicians are familiar with, endorse, and have participated in time-limited trials, and some older adults appear to favor time-limited trial strategies over indefinite life-sustaining therapy or care immediately focused on comfort. When time-limited trials are used, they are often implemented incompletely and challenged by systematic barriers (eg, continually rotating ICU staff). Predictive modeling studies support prevailing clinical wisdom that prognostic uncertainty decreases over time in the ICU for some patients. One study prospectively comparing usual ICU care with an intervention designed to support time-limited trials yielded promising preliminary results. Ethical analyses describe time-limited trials as a pragmatic approach within the longstanding discussion about withholding and withdrawing life-sustaining therapies.
SUMMARY: Time-limited trials are endorsed by physicians, align with the priorities of some older adults, and are part of current practice. Substantial efforts are needed to test their impact on patient-centered outcomes, improve their implementation, and maximize their potential benefit.
参考来源
- Kruser JM, Nadig NR, Viglianti EM, et al. Time-Limited Trials for Patients With Critical Illness: A Review of the Literature. Chest. 2023. PMID: 38101511. doi:10.1016/j.chest.2023.12.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。